Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes View Full Press Release Travere Therapeutics Reports First Quarter 2026 Financial Results Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes